Alzheimer’s Disease (AD) is progressive, neurodegenerative disease. It is most common in people ages 60-85, and the risk increases significantly as age increases. Memory impairment is typically the first symptom of AD, while problems with thinking, decision-making, simple task execution, and motor movements increase as the disease progresses(1,2). Symptoms of AD are caused by amyloid plaques and tau aggregates, which result in brain tissue inflammation, disrupted synapses, and nerve cell degeneration(3). Recent research suggests that decreased oxygen levels in the brain (due to decreased blood flow) causes amyloid plaque formation and the associated brain tissue damage(4, 5). Current AD treatments only target symptoms of AD and include cholinesterase inhibitors and N-methyl D-aspartate (NMDA) antagonists(6). However these classes of medications can have many adverse side effects and do not treat the rood cause of AD(7,8).
Extivita Therapies for Alzheimer’s Disease: